Post

New research · Ophthalmology
Journal francais d'ophtalmologie · 16h
Case reportJournal francais d'ophtalmologie · 2026

Orbital exenteration 14years after evisceration for misdiagnosed choroidal melanoma.

V Vermot-Desroches, E Baggio, M Espinasse … T Mathis
Read paper
OphthalmologyCase report

Choroidal melanoma recurred in the orbit 14 years after evisceration

Orbital exenteration 14years after evisceration for misdiagnosed choroidal melanoma.

V Vermot-Desroches … T Mathis
Journal francais d'ophtalmologie · 2026
14years
Results
14years
melanoma silently regrew in the eye socket over these years before detection
More results

Initially misdiagnosed as trauma-related, the patient's condition progressed, leading to neovascular glaucoma and retinal detachment.

Subsequent pain and complications prompted evisceration without a pathological evaluation.

Fourteen years later, an orbital mass was identified, leading to an orbital exenteration.

“
Conclusion

This case demonstrates the potential for long-term local-regional recurrence of choroidal melanoma and highlights the importance of thorough examination and pathological evaluation in cases of a painful, sightless eye to prevent delayed diagnoses and improve patient outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving